Targeting All <i>BRAF</i> Alterations: The (Re)-Search Continues.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 38380848.
- Also identified by DOI 10.1200/PO.23.00670 and PMC identifier 10896466.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
VivekSubbiah & colleagues delve into the @ASCO #TAPURStudy, shedding light on the importance of targeting ALL #BRAFAlterations, beyond V600E. (Re)-search continues, urging us to push the boundaries and unlock new possibilities in #PrecisionMedicine. #CancerResearch #JCOPO.
Medical subject headings
- Proto-Oncogene Proteins B-raf